Pre-Election Special SALE: 60% Off VIP Membership
BREAKING: Supreme Court Rules on Whether Virginia Can Remove Non-Citizens From Voter Rolls
Tim Walz's Gaming Session With Ocasio-Cortez Was a Trainwreck
Oregon Predicates Request to Judge on Self-Delusion
GDP Report Shows Economy 'Weaker Than Expected'
How Trump Plans to Help Compensate Victims of 'Migrant Crime'
NRCC Blasts the Left's Voter Suppression Efforts in Battleground Districts
Watch Trump's Reaction to Finding Out Biden Called His Supporters 'Garbage'
Scott Jennings Calls Out CNN Host, Panelists Trying to Desperately Explain Away Biden's...
There Was a Vile, Violent Attack in Chicago, and the Media's Been Silent....
One Red State Just Acquired a Massive Amount of Land to Secure Its...
Poll Out of Texas Shows That Harris Rally Sure Didn't Work for Colin...
This Hollywood Actor Is Persuading Christian Men to Vote for Kamala Harris
Is the Trump Campaign Over-Confident?
Is This Really How the Kamala HQ Is Going to Respond to Biden’s...
Tipsheet

Foreshadowing Report: UK Health System Failing Patients

Following the House Democrats' unveiling yesterday of their $1.5 trillion plan that would make government health care a right for all Americans (and illegal immigrants living here), the
Advertisement
Daily Mail coincidentally ran an article today about the long delays in treatment for rheumatoid arthritis patients in the UK. 

A new study by Britain's National Audit Office reports that patients suffering from agonizingly painful rheumatoid arthritis are having to wait an average of nine months to receive treatment. Apparently the fact that UK health guidelines specifically state that no patient should wait for treatment longer than three months following initial symptoms is not enough to speed up the process.  "On average it takes four visits before a patient is referred to a specialist for diagnosis and treatment."

It's also worth noting that the prescription drug Humira is widely available in the U.S. to treat some cases of rheumatoid arthritis.  However, because the drug is more costly than some other, less effective drugs, one commenter on the story says that it is only available to patients in the UK system after other a number of other meds have failed to control the condition.

I highly recommend reading comments on stories like this from countries with health care systems similar to what is being proposed in Congress to see just what we could be getting ourselves into.

Join the conversation as a VIP Member

Recommended

Trending on Townhall Videos

Advertisement
Advertisement
Advertisement